| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.12 | 0.07 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.5 | 0.07 |